

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.31236321 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.30447755 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 9.25176149 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55281920 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.55281920 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.22563817 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.22563817 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.81088431 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.50763054 |
| 10 | drug metabolic process (GO:0017144) | 6.43475141 |
| 11 | oxidative demethylation (GO:0070989) | 6.34274737 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.15912957 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 6.15912957 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 6.15912957 |
| 15 | ethanol metabolic process (GO:0006067) | 6.05811595 |
| 16 | kynurenine metabolic process (GO:0070189) | 6.01386717 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.94363971 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.83850010 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.79834991 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.76760663 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.76290744 |
| 22 | urea cycle (GO:0000050) | 5.68370018 |
| 23 | urea metabolic process (GO:0019627) | 5.68370018 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58431458 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.57114654 |
| 26 | protein carboxylation (GO:0018214) | 5.46580162 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.46580162 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.41155394 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.39901867 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.34064344 |
| 31 | cysteine metabolic process (GO:0006534) | 5.28921599 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.22430936 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 5.22209171 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.12165993 |
| 35 | bile acid metabolic process (GO:0008206) | 5.08328196 |
| 36 | reverse cholesterol transport (GO:0043691) | 5.07752706 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 5.03334250 |
| 38 | regulation of plasminogen activation (GO:0010755) | 5.03315172 |
| 39 | regulation of complement activation (GO:0030449) | 5.02991562 |
| 40 | S-adenosylmethionine metabolic process (GO:0046500) | 5.00997088 |
| 41 | negative regulation of protein activation cascade (GO:2000258) | 4.99188453 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.95269704 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.95054510 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.93746626 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.93746626 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.93746626 |
| 47 | regulation of humoral immune response (GO:0002920) | 4.92591181 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87000949 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.81741350 |
| 50 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.78664164 |
| 51 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.78664164 |
| 52 | phospholipid efflux (GO:0033700) | 4.74377503 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.70123085 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.69678661 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.69678661 |
| 56 | negative regulation of sterol transport (GO:0032372) | 4.62157029 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.62157029 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.62121778 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.59557150 |
| 60 | negative regulation of blood coagulation (GO:0030195) | 4.52385778 |
| 61 | negative regulation of hemostasis (GO:1900047) | 4.52385778 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.51749663 |
| 63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.49915458 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.49449832 |
| 65 | lysine catabolic process (GO:0006554) | 4.48195222 |
| 66 | lysine metabolic process (GO:0006553) | 4.48195222 |
| 67 | glycine metabolic process (GO:0006544) | 4.39141680 |
| 68 | bile acid and bile salt transport (GO:0015721) | 4.38934803 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.37202298 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.35644739 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 4.34008836 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.29703251 |
| 73 | amine catabolic process (GO:0009310) | 4.29703251 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.25008761 |
| 75 | cellular glucuronidation (GO:0052695) | 4.22122316 |
| 76 | glutamate metabolic process (GO:0006536) | 4.19453298 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.13961534 |
| 78 | negative regulation of coagulation (GO:0050819) | 4.12739744 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.11578710 |
| 80 | negative regulation of complement activation (GO:0045916) | 4.11283714 |
| 81 | fibrinolysis (GO:0042730) | 4.10483716 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 4.10337434 |
| 83 | * cholesterol efflux (GO:0033344) | 4.09145068 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08795402 |
| 85 | negative regulation of wound healing (GO:0061045) | 4.08565038 |
| 86 | alkaloid metabolic process (GO:0009820) | 4.08523318 |
| 87 | arginine metabolic process (GO:0006525) | 4.04554573 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 4.03416223 |
| 89 | aldehyde catabolic process (GO:0046185) | 4.03209558 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03024260 |
| 91 | ethanol oxidation (GO:0006069) | 4.00855837 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.99229984 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.98985163 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93602615 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93602615 |
| 96 | ketone body metabolic process (GO:1902224) | 3.90949000 |
| 97 | drug catabolic process (GO:0042737) | 3.85102507 |
| 98 | positive regulation of blood coagulation (GO:0030194) | 3.83247433 |
| 99 | positive regulation of hemostasis (GO:1900048) | 3.83247433 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.83022779 |
| 101 | cofactor catabolic process (GO:0051187) | 3.80869683 |
| 102 | complement activation, classical pathway (GO:0006958) | 3.80633150 |
| 103 | protein activation cascade (GO:0072376) | 3.79781751 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.79662908 |
| 105 | phospholipid homeostasis (GO:0055091) | 3.79608854 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78593538 |
| 107 | complement activation (GO:0006956) | 3.77053481 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.76899860 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.75169145 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.75169145 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.74807461 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.72304192 |
| 113 | organic acid catabolic process (GO:0016054) | 3.72304192 |
| 114 | sterol homeostasis (GO:0055092) | 3.70521401 |
| 115 | acute inflammatory response (GO:0002526) | 3.69522701 |
| 116 | cytolysis (GO:0019835) | 3.67795194 |
| 117 | protein-lipid complex assembly (GO:0065005) | 3.66225983 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65120924 |
| 119 | flavonoid metabolic process (GO:0009812) | 3.63717807 |
| 120 | NAD biosynthetic process (GO:0009435) | 3.61510851 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.61093819 |
| 122 | opsonization (GO:0008228) | 3.58651474 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 3.58341184 |
| 124 | acute-phase response (GO:0006953) | 3.57914604 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 3.57342248 |
| 126 | xenobiotic metabolic process (GO:0006805) | 3.54376837 |
| 127 | positive regulation of coagulation (GO:0050820) | 3.50822820 |
| 128 | regulation of acute inflammatory response (GO:0002673) | 3.48805125 |
| 129 | hormone catabolic process (GO:0042447) | 3.45679229 |
| 130 | heme transport (GO:0015886) | 3.45607769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38899027 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18091913 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.13362504 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49089176 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30541760 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.21253836 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77614596 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.07449349 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05802803 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06940688 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9801938 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99914002 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90528940 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60468770 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60181365 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52249123 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48589689 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46102205 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40661303 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27050827 |
| 21 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26975049 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24461663 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24107009 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22536752 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21418063 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20505759 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19214396 |
| 28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17209280 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12467631 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11253532 |
| 31 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10281668 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08440480 |
| 33 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.08268363 |
| 34 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07591383 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06550924 |
| 36 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05179104 |
| 37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02947599 |
| 38 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98627617 |
| 39 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98381203 |
| 40 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96671845 |
| 41 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95436273 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94220811 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93729372 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91963473 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90873221 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90843763 |
| 47 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89700612 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89649358 |
| 49 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88193315 |
| 50 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88193315 |
| 51 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.85270128 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85118121 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84061483 |
| 54 | NFYA_21822215_ChIP-Seq_K562_Human | 0.83919892 |
| 55 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83839595 |
| 56 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83107606 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81780993 |
| 58 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.80465339 |
| 59 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80451534 |
| 60 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79893416 |
| 61 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.79786887 |
| 62 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.79323577 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.79323577 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.78730108 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78599770 |
| 66 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.78466893 |
| 67 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.78049960 |
| 68 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77892133 |
| 69 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.77747835 |
| 70 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77399286 |
| 71 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.76717252 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.76529687 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75903773 |
| 74 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75747574 |
| 75 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.75628452 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74694194 |
| 77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.73773406 |
| 78 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.73773406 |
| 79 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.73191473 |
| 80 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73099138 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.72384178 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.72294259 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72058113 |
| 84 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71943650 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 0.71099960 |
| 86 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.70862995 |
| 87 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.70813283 |
| 88 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.69611101 |
| 89 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69492801 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69389708 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69235454 |
| 92 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.68710950 |
| 93 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68616333 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.68300596 |
| 95 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.67631684 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67131804 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66207712 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66207712 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66043090 |
| 100 | NFYB_21822215_ChIP-Seq_K562_Human | 0.65810777 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64043473 |
| 102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62969576 |
| 103 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62646566 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62380263 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61478646 |
| 106 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.61013665 |
| 107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.59703306 |
| 108 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.58599301 |
| 109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56819940 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55659670 |
| 111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55053797 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.54702364 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53131489 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53022341 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52631804 |
| 116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51293512 |
| 117 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50669556 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49009436 |
| 119 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48759282 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.48474093 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48291567 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47266579 |
| 123 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46385400 |
| 124 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45959264 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.45466185 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45279163 |
| 127 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.44833779 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44391237 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43714284 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43713721 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42565321 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42355245 |
| 133 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41473390 |
| 134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.41396580 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40548622 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40225224 |
| 137 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39846204 |
| 138 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39806402 |
| 139 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39705616 |
| 140 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.39222947 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39216788 |
| 142 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39179100 |
| 143 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37679886 |
| 144 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37031511 |
| 145 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36770123 |
| 146 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.36488842 |
| 147 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36302722 |
| 148 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35522751 |
| 149 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.35485349 |
| 150 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35286294 |
| 151 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34746624 |
| 152 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34637466 |
| 153 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34071429 |
| 154 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33612712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.33470445 |
| 2 | MP0005360_urolithiasis | 7.50779636 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44967028 |
| 4 | MP0005365_abnormal_bile_salt | 6.18765235 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.06570089 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26851598 |
| 7 | MP0003252_abnormal_bile_duct | 3.90524744 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.62648659 |
| 9 | MP0009840_abnormal_foam_cell | 3.34050901 |
| 10 | MP0005083_abnormal_biliary_tract | 3.05305704 |
| 11 | MP0003195_calcinosis | 2.84631139 |
| 12 | MP0005332_abnormal_amino_acid | 2.73885246 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59250272 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.43782755 |
| 15 | MP0000609_abnormal_liver_physiology | 2.16770890 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14526660 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09798765 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00987293 |
| 19 | MP0003868_abnormal_feces_composition | 1.94717435 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82386387 |
| 21 | MP0001764_abnormal_homeostasis | 1.71006115 |
| 22 | MP0009697_abnormal_copulation | 1.69284729 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56150230 |
| 24 | MP0005451_abnormal_body_composition | 1.44434773 |
| 25 | MP0003011_delayed_dark_adaptation | 1.44183052 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.30755706 |
| 27 | MP0003186_abnormal_redox_activity | 1.28866747 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.21849111 |
| 29 | MP0000598_abnormal_liver_morphology | 1.17668027 |
| 30 | MP0005647_abnormal_sex_gland | 1.17564526 |
| 31 | MP0002282_abnormal_trachea_morphology | 1.12751217 |
| 32 | MP0000604_amyloidosis | 1.10528293 |
| 33 | MP0009764_decreased_sensitivity_to | 1.10180932 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.07497875 |
| 35 | MP0002254_reproductive_system_inflammat | 1.04396049 |
| 36 | MP0009763_increased_sensitivity_to | 1.03534389 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.99057726 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.93253293 |
| 39 | MP0008469_abnormal_protein_level | 0.91183773 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.87825468 |
| 41 | MP0005408_hypopigmentation | 0.86706821 |
| 42 | MP0002876_abnormal_thyroid_physiology | 0.83375589 |
| 43 | MP0005187_abnormal_penis_morphology | 0.81744741 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 0.80878627 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.80452413 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.80151342 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.77777022 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.76952536 |
| 49 | MP0005670_abnormal_white_adipose | 0.75902876 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.72679066 |
| 51 | MP0002971_abnormal_brown_adipose | 0.68919362 |
| 52 | MP0005334_abnormal_fat_pad | 0.68296155 |
| 53 | MP0003690_abnormal_glial_cell | 0.66960896 |
| 54 | MP0005535_abnormal_body_temperature | 0.65653932 |
| 55 | MP0001661_extended_life_span | 0.65059715 |
| 56 | MP0009053_abnormal_anal_canal | 0.64969193 |
| 57 | MP0004130_abnormal_muscle_cell | 0.64526671 |
| 58 | MP0005266_abnormal_metabolism | 0.62175408 |
| 59 | MP0000639_abnormal_adrenal_gland | 0.62012871 |
| 60 | MP0001986_abnormal_taste_sensitivity | 0.60483621 |
| 61 | MP0006292_abnormal_olfactory_placode | 0.59820926 |
| 62 | MP0001915_intracranial_hemorrhage | 0.59224471 |
| 63 | MP0005464_abnormal_platelet_physiology | 0.57492732 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.57460995 |
| 65 | MP0001756_abnormal_urination | 0.57213357 |
| 66 | MP0003329_amyloid_beta_deposits | 0.57051032 |
| 67 | MP0009785_altered_susceptibility_to | 0.55732540 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.55129564 |
| 69 | MP0005448_abnormal_energy_balance | 0.54728620 |
| 70 | MP0005646_abnormal_pituitary_gland | 0.50871823 |
| 71 | MP0005395_other_phenotype | 0.50582237 |
| 72 | MP0002822_catalepsy | 0.49118274 |
| 73 | MP0003718_maternal_effect | 0.48324450 |
| 74 | MP0000566_synostosis | 0.47847085 |
| 75 | MP0003879_abnormal_hair_cell | 0.47268994 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.46955522 |
| 77 | MP0003724_increased_susceptibility_to | 0.46472823 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.46294333 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.45231858 |
| 80 | MP0003436_decreased_susceptibility_to | 0.44970286 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.44290002 |
| 82 | MP0002928_abnormal_bile_duct | 0.44240345 |
| 83 | MP0008874_decreased_physiological_sensi | 0.43545817 |
| 84 | MP0008873_increased_physiological_sensi | 0.43108709 |
| 85 | MP0004381_abnormal_hair_follicle | 0.42596933 |
| 86 | MP0003075_altered_response_to | 0.40879838 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.40801509 |
| 88 | MP0003953_abnormal_hormone_level | 0.40365313 |
| 89 | MP0005166_decreased_susceptibility_to | 0.39106244 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.37485331 |
| 91 | MP0008872_abnormal_physiological_respon | 0.36433055 |
| 92 | MP0004883_abnormal_blood_vessel | 0.35225152 |
| 93 | MP0009672_abnormal_birth_weight | 0.33771952 |
| 94 | MP0000579_abnormal_nail_morphology | 0.33771657 |
| 95 | MP0002132_abnormal_respiratory_system | 0.33723539 |
| 96 | MP0006082_CNS_inflammation | 0.33342326 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.33215161 |
| 98 | MP0004142_abnormal_muscle_tone | 0.33137773 |
| 99 | MP0000249_abnormal_blood_vessel | 0.33067681 |
| 100 | MP0001243_abnormal_dermal_layer | 0.31626768 |
| 101 | MP0009115_abnormal_fat_cell | 0.31250901 |
| 102 | MP0002796_impaired_skin_barrier | 0.31101629 |
| 103 | MP0002168_other_aberrant_phenotype | 0.30455191 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.30455150 |
| 105 | MP0009384_cardiac_valve_regurgitation | 0.30049340 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.30001339 |
| 107 | MP0001853_heart_inflammation | 0.29985841 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.28616301 |
| 109 | MP0002970_abnormal_white_adipose | 0.27924678 |
| 110 | MP0005164_abnormal_response_to | 0.27561063 |
| 111 | MP0001881_abnormal_mammary_gland | 0.27535547 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.27027722 |
| 113 | MP0001944_abnormal_pancreas_morphology | 0.24233510 |
| 114 | MP0004043_abnormal_pH_regulation | 0.23338449 |
| 115 | MP0002060_abnormal_skin_morphology | 0.23030109 |
| 116 | MP0000427_abnormal_hair_cycle | 0.22245078 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.21652476 |
| 118 | MP0003633_abnormal_nervous_system | 0.21581002 |
| 119 | MP0005023_abnormal_wound_healing | 0.21193379 |
| 120 | MP0002135_abnormal_kidney_morphology | 0.21150084 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.20148801 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.19416881 |
| 123 | MP0001324_abnormal_eye_pigmentation | 0.18330892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.51975196 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39081365 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.32105710 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.79128893 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64994027 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.47982031 |
| 7 | Xanthomatosis (HP:0000991) | 6.29580810 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.65255079 |
| 9 | Complement deficiency (HP:0004431) | 5.43811435 |
| 10 | Joint hemorrhage (HP:0005261) | 4.99437451 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.89315433 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.60276437 |
| 13 | Hyperammonemia (HP:0001987) | 4.58942077 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.47087314 |
| 15 | Epidermoid cyst (HP:0200040) | 4.45955597 |
| 16 | Hyperglycinemia (HP:0002154) | 4.40193810 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.31927346 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.31445764 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23285220 |
| 20 | Ketosis (HP:0001946) | 4.21409178 |
| 21 | Fat malabsorption (HP:0002630) | 4.15605153 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11887777 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08807677 |
| 24 | Abnormality of complement system (HP:0005339) | 3.97540442 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.90053759 |
| 26 | Hyperglycinuria (HP:0003108) | 3.87091015 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.86981048 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.85846548 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85772212 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.85772212 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74207804 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.60442851 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36130670 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.35905578 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.34418663 |
| 36 | Spontaneous abortion (HP:0005268) | 3.19872968 |
| 37 | Fair hair (HP:0002286) | 3.18946444 |
| 38 | Steatorrhea (HP:0002570) | 3.15236397 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.07426345 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.06287023 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 3.05610617 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03755089 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.01162992 |
| 44 | Ketoacidosis (HP:0001993) | 2.94866364 |
| 45 | Myocardial infarction (HP:0001658) | 2.94260108 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.79230274 |
| 47 | Metabolic acidosis (HP:0001942) | 2.75938037 |
| 48 | Neonatal hypoglycemia (HP:0001998) | 2.74964430 |
| 49 | Skin nodule (HP:0200036) | 2.71552590 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.62142109 |
| 51 | Lethargy (HP:0001254) | 2.59358555 |
| 52 | Vascular calcification (HP:0004934) | 2.59310846 |
| 53 | Acanthocytosis (HP:0001927) | 2.57833387 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.56534843 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56534843 |
| 56 | Glomerulonephritis (HP:0000099) | 2.53854009 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.50568990 |
| 58 | Osteomalacia (HP:0002749) | 2.46795070 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.44633284 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.42384298 |
| 61 | Cerebral edema (HP:0002181) | 2.41914025 |
| 62 | Amyloidosis (HP:0011034) | 2.41658758 |
| 63 | Spastic diplegia (HP:0001264) | 2.40213189 |
| 64 | Mitral stenosis (HP:0001718) | 2.39281705 |
| 65 | Cholelithiasis (HP:0001081) | 2.37702234 |
| 66 | Gout (HP:0001997) | 2.35711988 |
| 67 | Gingival bleeding (HP:0000225) | 2.35651134 |
| 68 | Irritability (HP:0000737) | 2.31924229 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.30415798 |
| 70 | Cholecystitis (HP:0001082) | 2.30415798 |
| 71 | Neonatal onset (HP:0003623) | 2.30380117 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.29553831 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.29263062 |
| 74 | Purpura (HP:0000979) | 2.28925333 |
| 75 | Generalized hypopigmentation of hair (HP:0011358) | 2.25272672 |
| 76 | Menorrhagia (HP:0000132) | 2.23138424 |
| 77 | Malnutrition (HP:0004395) | 2.22882940 |
| 78 | Arthropathy (HP:0003040) | 2.20300042 |
| 79 | Pancreatitis (HP:0001733) | 2.18540900 |
| 80 | Esophageal varix (HP:0002040) | 2.18332656 |
| 81 | Thrombophlebitis (HP:0004418) | 2.16426843 |
| 82 | Enlarged kidneys (HP:0000105) | 2.15747497 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.12244008 |
| 84 | Brushfield spots (HP:0001088) | 2.11243379 |
| 85 | Late onset (HP:0003584) | 2.05925456 |
| 86 | Vomiting (HP:0002013) | 2.05689208 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.05129973 |
| 88 | Poikilocytosis (HP:0004447) | 2.04711217 |
| 89 | Opisthotonus (HP:0002179) | 2.02266513 |
| 90 | Hyperphosphaturia (HP:0003109) | 2.01759195 |
| 91 | Glycosuria (HP:0003076) | 2.01324756 |
| 92 | Abnormality of urine glucose concentration (HP:0011016) | 2.01324756 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99980096 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 1.99492998 |
| 95 | Hemorrhage of the eye (HP:0011885) | 1.98596395 |
| 96 | Rickets (HP:0002748) | 1.92830213 |
| 97 | Renal cortical cysts (HP:0000803) | 1.92778606 |
| 98 | Joint swelling (HP:0001386) | 1.91458025 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.90313491 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87618686 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.87451628 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 1.83821994 |
| 103 | Elevated hepatic transaminases (HP:0002910) | 1.83101572 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 1.81644800 |
| 105 | Hydroxyprolinuria (HP:0003080) | 1.81644800 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80143860 |
| 107 | Nephritis (HP:0000123) | 1.78868607 |
| 108 | Blue irides (HP:0000635) | 1.77371628 |
| 109 | Alkalosis (HP:0001948) | 1.77246370 |
| 110 | Status epilepticus (HP:0002133) | 1.76474261 |
| 111 | Gangrene (HP:0100758) | 1.73108732 |
| 112 | Pulmonary embolism (HP:0002204) | 1.72241474 |
| 113 | Increased serum ferritin (HP:0003281) | 1.72122316 |
| 114 | Abnormal biliary tract physiology (HP:0012439) | 1.71630849 |
| 115 | Bile duct proliferation (HP:0001408) | 1.71630849 |
| 116 | Cerebral palsy (HP:0100021) | 1.71536890 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 1.71521915 |
| 118 | Increased serum pyruvate (HP:0003542) | 1.70698703 |
| 119 | Facial shape deformation (HP:0011334) | 1.67102566 |
| 120 | Potter facies (HP:0002009) | 1.67102566 |
| 121 | Epistaxis (HP:0000421) | 1.63943035 |
| 122 | Abnormal urine phosphate concentration (HP:0012599) | 1.55278035 |
| 123 | Elevated alkaline phosphatase (HP:0003155) | 1.55218857 |
| 124 | Abnormality of alanine metabolism (HP:0010916) | 1.50903478 |
| 125 | Hyperalaninemia (HP:0003348) | 1.50903478 |
| 126 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.50903478 |
| 127 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.45623070 |
| 128 | Bifid scrotum (HP:0000048) | 1.44704194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.32029299 |
| 2 | FGFR4 | 4.64413776 |
| 3 | SIK1 | 4.50227072 |
| 4 | ERN1 | 4.41747138 |
| 5 | TAOK3 | 3.20558954 |
| 6 | INSRR | 3.10125354 |
| 7 | ERBB4 | 2.89790543 |
| 8 | MAP2K4 | 2.30569674 |
| 9 | BRSK2 | 2.24503320 |
| 10 | WNK3 | 2.22838513 |
| 11 | MST1R | 2.09865984 |
| 12 | CAMKK2 | 2.03181527 |
| 13 | PKN2 | 2.01012795 |
| 14 | FLT3 | 1.90364156 |
| 15 | MAPK11 | 1.90197797 |
| 16 | PIK3CG | 1.88038331 |
| 17 | TYK2 | 1.77547852 |
| 18 | ADRBK2 | 1.75716390 |
| 19 | LATS1 | 1.63387079 |
| 20 | ZAK | 1.60443689 |
| 21 | MAP4K2 | 1.59426842 |
| 22 | DAPK2 | 1.55277806 |
| 23 | WNK4 | 1.54427731 |
| 24 | TRIB3 | 1.52525442 |
| 25 | NEK9 | 1.47709243 |
| 26 | ABL2 | 1.47692698 |
| 27 | NLK | 1.46253137 |
| 28 | PTK6 | 1.42774498 |
| 29 | FRK | 1.41691988 |
| 30 | NTRK3 | 1.39511158 |
| 31 | TNK2 | 1.39495811 |
| 32 | KDR | 1.33109291 |
| 33 | STK16 | 1.31395636 |
| 34 | BMPR1B | 1.28156253 |
| 35 | FGFR2 | 1.25934365 |
| 36 | JAK2 | 1.22829012 |
| 37 | PINK1 | 1.21683841 |
| 38 | MAP3K14 | 1.15324841 |
| 39 | MAP3K7 | 1.11140546 |
| 40 | PDK2 | 1.10525434 |
| 41 | PRKAA2 | 1.10222720 |
| 42 | PRKG1 | 1.08901843 |
| 43 | DYRK2 | 1.07867641 |
| 44 | JAK1 | 1.07255653 |
| 45 | NUAK1 | 1.06850608 |
| 46 | TBK1 | 1.06519004 |
| 47 | MAP3K4 | 1.06429330 |
| 48 | MAP2K3 | 1.05829932 |
| 49 | PRKACA | 1.03239004 |
| 50 | GRK6 | 1.02791621 |
| 51 | FER | 1.02696164 |
| 52 | STK38L | 0.99785326 |
| 53 | ERBB2 | 0.99766666 |
| 54 | MAPK4 | 0.99399380 |
| 55 | BCR | 0.97749956 |
| 56 | MAP3K3 | 0.92039999 |
| 57 | MAPKAPK3 | 0.91986332 |
| 58 | TIE1 | 0.91293773 |
| 59 | EPHA3 | 0.90711650 |
| 60 | PRKCZ | 0.90544836 |
| 61 | MAPK13 | 0.89059620 |
| 62 | EPHB1 | 0.84647612 |
| 63 | MAP3K10 | 0.83558903 |
| 64 | MAPK15 | 0.82777696 |
| 65 | MAPK12 | 0.81581607 |
| 66 | PAK3 | 0.81564769 |
| 67 | STK39 | 0.80886538 |
| 68 | TRIM28 | 0.80819331 |
| 69 | PRKCE | 0.79792873 |
| 70 | CSNK1D | 0.78417914 |
| 71 | MET | 0.78051740 |
| 72 | IRAK3 | 0.77940996 |
| 73 | MAP3K11 | 0.77231328 |
| 74 | PRKACG | 0.76824840 |
| 75 | TLK1 | 0.76756614 |
| 76 | CDK6 | 0.76099349 |
| 77 | VRK1 | 0.75660830 |
| 78 | EIF2AK3 | 0.75311755 |
| 79 | CAMK2G | 0.71254413 |
| 80 | TXK | 0.70686801 |
| 81 | CASK | 0.70330599 |
| 82 | CSK | 0.69256081 |
| 83 | DYRK1B | 0.68462672 |
| 84 | MAP2K6 | 0.68295477 |
| 85 | SGK3 | 0.67939725 |
| 86 | ACVR1B | 0.64746751 |
| 87 | GSK3A | 0.64504608 |
| 88 | PRKAA1 | 0.64013311 |
| 89 | IKBKE | 0.63124300 |
| 90 | CSNK1E | 0.62877396 |
| 91 | CAMK1D | 0.62514495 |
| 92 | MAPK7 | 0.62091853 |
| 93 | TGFBR2 | 0.61821714 |
| 94 | TSSK6 | 0.59432589 |
| 95 | CSNK2A1 | 0.58630285 |
| 96 | FGFR3 | 0.58512553 |
| 97 | GRK1 | 0.58087675 |
| 98 | TEC | 0.57399028 |
| 99 | SGK2 | 0.56950634 |
| 100 | CSNK1A1 | 0.56462791 |
| 101 | TAOK2 | 0.55918717 |
| 102 | CSF1R | 0.55862463 |
| 103 | PRKCB | 0.55143564 |
| 104 | PRKCQ | 0.53870954 |
| 105 | PRKACB | 0.53254964 |
| 106 | EIF2AK2 | 0.51519639 |
| 107 | RPS6KA3 | 0.50460011 |
| 108 | PTK2 | 0.48507076 |
| 109 | PDPK1 | 0.48405272 |
| 110 | CSNK1G1 | 0.46389045 |
| 111 | EIF2AK1 | 0.46190128 |
| 112 | RIPK1 | 0.45176355 |
| 113 | MAP3K5 | 0.45008374 |
| 114 | PKN1 | 0.44726560 |
| 115 | IGF1R | 0.43927059 |
| 116 | CSNK2A2 | 0.43214729 |
| 117 | CSNK1A1L | 0.42995609 |
| 118 | EPHA4 | 0.42549235 |
| 119 | PRKCG | 0.42437663 |
| 120 | SRPK1 | 0.41729155 |
| 121 | AKT3 | 0.41410942 |
| 122 | IKBKB | 0.41085850 |
| 123 | NEK1 | 0.38904907 |
| 124 | PBK | 0.38617461 |
| 125 | SGK1 | 0.38254309 |
| 126 | MAP2K1 | 0.38033935 |
| 127 | SGK494 | 0.36974791 |
| 128 | SGK223 | 0.36974791 |
| 129 | CDK4 | 0.36769126 |
| 130 | BRSK1 | 0.34916532 |
| 131 | CAMK4 | 0.34647742 |
| 132 | GRK5 | 0.34162529 |
| 133 | MAPKAPK5 | 0.33969017 |
| 134 | RPS6KB1 | 0.33653592 |
| 135 | RET | 0.33207130 |
| 136 | MAP3K6 | 0.32993531 |
| 137 | EGFR | 0.31902724 |
| 138 | MAP3K13 | 0.31703463 |
| 139 | IRAK1 | 0.31141137 |
| 140 | PDK1 | 0.29269434 |
| 141 | MTOR | 0.26780530 |
| 142 | ICK | 0.26633067 |
| 143 | PRKCA | 0.26574846 |
| 144 | MAP3K1 | 0.25021097 |
| 145 | IRAK2 | 0.24943956 |
| 146 | CSNK1G2 | 0.24022207 |
| 147 | PIK3CA | 0.23679783 |
| 148 | CSNK1G3 | 0.22401153 |
| 149 | ABL1 | 0.21335996 |
| 150 | MAPK3 | 0.20324647 |
| 151 | MAP2K2 | 0.19290114 |
| 152 | KIT | 0.18279928 |
| 153 | CHUK | 0.17188889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54123544 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56048907 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37560044 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33353190 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06706081 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85722664 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71385163 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67959914 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63512497 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54425135 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48277120 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38090768 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24155869 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14285969 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12629741 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09258342 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94886347 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92939988 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92204947 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91563011 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90563342 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86843755 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81925512 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81460593 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75714063 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73391591 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71604663 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70313133 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69421783 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66339910 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65881038 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57184252 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56615372 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54123780 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47718165 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.46368133 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44715759 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38444379 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36569346 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34441909 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31972466 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27452511 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22584978 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21374918 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19661995 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17906650 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17535507 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10315720 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04254837 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02266493 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00370401 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97106669 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97043531 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97038760 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96015701 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91238032 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88270366 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.79860914 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78970032 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78277789 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67587595 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65634057 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64281156 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56425891 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52583579 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46669496 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42236331 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41151162 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.36949152 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27092885 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26379336 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23927381 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23223349 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.21275485 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20874366 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19996108 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15252357 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07950082 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.05830761 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.00190219 |
| 81 | Pertussis_Homo sapiens_hsa05133 | -0.2492663 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | -0.2458030 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2440415 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2434174 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2349633 |
| 86 | GABAergic synapse_Homo sapiens_hsa04727 | -0.2303676 |
| 87 | Protein export_Homo sapiens_hsa03060 | -0.2248775 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2089374 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2082344 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2048039 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1992527 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1907257 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1819102 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1803490 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1766656 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1690082 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1467766 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1385440 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1298938 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1287328 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1187388 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1183998 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1079305 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0871060 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0651604 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0508089 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0439790 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0386266 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0033028 |

